Skip to main content
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc. — Investor Relations & Filings

Ticker · NERV ISIN · US6033802058 LEI · 54930017PANCHC5LYH79 US Manufacturing
Open in API
Filings indexed 589 across all filing types
Latest filing 2016-06-17 Director's Dealing
Country US United States of America
Listing US NERV

About Minerva Neurosciences, Inc.

https://www.minervaneurosciences.com/

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of product candidates for the treatment of central nervous system (CNS) diseases. The company's lead product candidate is roluperidone, which is being developed to treat the negative symptoms of schizophrenia. Minerva Neurosciences leverages its expertise in clinical development to design innovative trials with clinical endpoints aimed at demonstrating direct patient benefit.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2016-06-17 English
FORM 4 SUBMISSION
Director's Dealing
2016-06-17 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 16, 2016, for Minerva Neurosciences, Inc. The key content is the submission of matters to a vote of security holders at the Annual Meeting held on June 16, 2016. It details the voting results for the election of directors and ratification of the independent auditor. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is short (2933 characters) and contains official voting results, not a full annual report or other detailed financial data. Therefore, the correct classification is DVA with high confidence.
2016-06-17 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement related to an underwriting agreement for a public offering of common stock. It includes details about the offering price, number of shares, and related legal opinions. There are no financial statements or detailed financial performance data included, only the announcement of a financing event. This fits the category of a Capital/Financing Update, as it provides an update on the company's fundraising activities and capital structure changes. The document length is over 7,000 characters, so it is not a brief announcement of a report publication. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2016-06-14 English
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a 'Prospectus Supplement' filed pursuant to Rule 424(b)(5) related to a public offering of common stock. It includes detailed information about the offering, underwriting, risk factors, use of proceeds, and company overview. This type of document is a capital raising disclosure used to inform investors about a new share issuance. It is not a financial report, earnings release, management discussion, or any other type of report. It is specifically related to financing activities and capital structure changes. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, supporting a high confidence level.
2016-06-14 English
424B5
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement and accompanying prospectus related to an offering of common stock. It includes detailed information about the offering, risk factors, use of proceeds, underwriting, and company overview. The document is filed pursuant to Rule 424(b)(5), which is a SEC rule related to prospectus supplements for securities offerings. The content focuses on the terms of the stock offering, company background, and investment risks, which are typical of capital raising documents. There is no indication of financial statements, audit reports, earnings releases, or other types of reports. This document is clearly an update or supplement to a registration statement for a securities offering, which fits the category of Capital/Financing Update (CAP).
2016-06-13 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.